{"DataElement":{"publicId":"5806511","version":"2","preferredName":"Free Radioiodine Iobenguane Detection Percentage Value","preferredDefinition":"The numeric value related to the percentage of free radioiodine that was detected in iobenguane.","longName":"MIBG_FR_Fe_Dtc_Pct","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5806508","version":"2","preferredName":"Free Radioiodine Iobenguane Detection","preferredDefinition":"Radioactive iodine that is not attached to another molecule.:A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells._The activity of perceiving, discerning, discovering or identifying.","longName":"5806506v1.0:2528336v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"8028540","version":"1","preferredName":"Free Radioiodine","preferredDefinition":"Radioactive iodine that is not attached to another molecule.","longName":"C133759","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Free Radioiodine","conceptCode":"C133759","definition":"Radioactive iodine that is not attached to another molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7353C82-C2AB-0543-E053-4EBD850A74AE","latestVersionIndicator":"Yes","beginDate":"2022-02-04","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-04","modifiedBy":"ONEDATA","dateModified":"2022-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"11167545","version":"1","preferredName":"Iobenguane Detection","preferredDefinition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells._The activity of perceiving, discerning, discovering or identifying.","longName":"C87757:C16210","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iobenguane","conceptCode":"C87757","definition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E79E1827-806A-79F6-E053-731AD00A4AA8","latestVersionIndicator":"Yes","beginDate":"2022-09-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-09-01","modifiedBy":"KUMMEROA","dateModified":"2022-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D785E4D0-A69B-4E81-E053-4EBD850A2CFD","latestVersionIndicator":"Yes","beginDate":"2017-05-03","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-08","modifiedBy":"KUMMEROA","dateModified":"2022-09-01","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18;  The DEC was reworked: Free Radioiodine is now the primary concept _2/8/22_TI","administrativeNotes":"2022.9.1 Reviewed and released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2199529","version":"1.1","preferredName":"Percentage Value","preferredDefinition":"A fraction or ratio with 100 understood as the denominator._A numerical quantity measured or assigned or computed.","longName":"PTG_VAL","context":"CCR","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03BC56FB-E71D-02CF-E050-BB89AD430891","latestVersionIndicator":"Yes","beginDate":"2014-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-09-23","modifiedBy":"REEVESD","dateModified":"2014-09-23","changeDescription":"VD v1.1 replaces v1.0 with a name change.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Percentage of free radioiodin","type":"Preferred Question Text","description":"Percentage of free radioiodine:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D78512BD-9CB2-1635-E053-4EBD850A8D46","latestVersionIndicator":"Yes","beginDate":"2017-05-03","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-08","modifiedBy":"KUMMEROA","dateModified":"2022-09-01","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18; The CDE has been versioned due to the DEC updates and version change and minor changes to the definition_2/8/22_TI","administrativeNotes":"2022.9.1 Added human readable def and released. ak","unresolvedIssues":null,"deletedIndicator":"No"}}